| Factor Information | |
|---|---|
| Data ID | 168 |
| Factor | Z score FVC |
| Description | N/A |
| Biomarker | NA |
| Classification | E10 (physiological factor - other) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | Impaired pulmonary function |
| p Value | <0.0001 |
| Conclusion | These results suggest that pulmonary function should be monitored early in life, from childhood, in the CHD population. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 422 |
| CHD Type | isolated CHD |
| CHD Subtype | TOF/TA/PA/DORV/CoA/VSD/TGA/PVS/CACA/other |
| Reference | |
|---|---|
| PMID | 30857849 |
| Year | 2019 |
| Title | Impaired pulmonary function and its association with clinical outcomes, exercise capacity and quality of life in children with congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | Children | |
| Source | questionnaire | |
| Region | Montpellier, France | |
| Method | Cross-sectional multicentre study, a complete spirometry and a cardiopulmonary exercise test (CPET). | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | CHD(Treatment) | Control(Control) |
| Number | 555 | 279 |
| Age | 12.2 ± 3.3 | 11.1 ± 2.6 |
| Gender (Male: Female) | 324:231 | 158:121 |
| Marker Level | −0.4 ± 1.5 | 0.4 ± 1.3 |
